Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Prostatic Neoplasms
Medicine & Life Sciences
Prostate-Specific Antigen
Medicine & Life Sciences
Peptide Hydrolases
Medicine & Life Sciences
Peptides
Medicine & Life Sciences
Urokinase Plasminogen Activator Receptors
Medicine & Life Sciences
Urokinase-Type Plasminogen Activator
Medicine & Life Sciences
Heterografts
Medicine & Life Sciences
Molecular Imaging
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2014 2024
CD133-Targeted Natural Killer Cell Therapy for Aggressive Prostate Cancer
8/1/19 → 7/31/22
Project: Research project
Cell- and Tissue-Based Therapy
Natural Killer Cells
Prostatic Neoplasms
Targeting CD133 for imaging and therapy in prostate cancer
LeBeau, A., Jallow, N. & Murugan, P.
NIH NATIONAL CANCER INSTITUTE (NCI)
7/1/19 → 6/30/24
Project: Research project
Prostatic Neoplasms
Therapeutics
Novel Radioimmunotherapy Strategies for Prostate Cancer
NIH NATIONAL CANCER INSTITUTE (NCI)
7/1/19 → 6/30/24
Project: Research project
Radioimmunotherapy
Prostatic Neoplasms
Cancer Center Support Grant
Yee, D., AbuSalah, A. M., Basu, S., Beckman, K. B., Bielinsky, A. K., Cooley, S. A., De For, T. E., Falconer, S. N., Felices, M., Griffin, T. J., Hallstrom, T. C., Hatsukami, D. K., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Koopmeiners, J., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Le, C. T., LeBeau, A., Lindgren, B. R., Luo, X., Mc Carthy, J. B., McKenna, D. H., Miller, J. S., Moriarity, B. S., Nelson, H. H., O'Sullivan, G., Ondrey, F. G., Pennell, C. A., Petersen, A. J., Peterson, B. A., Peterson, L. A., Sarver, A. L., Shimizu, Y., Siegfried, J. M., Temiz, N. A., Turesky, R., Vogel, R., Wagner, J. E., Wang, J., Weigel, B. J., Weisdorf, D. J., Woo, J. & Yamamoto, M.
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/19 → 1/31/24
Project: Research project
Neoplasms
CD133-Targeted Natural Killer Cell Therapy for Aggressive Variant Prostate Cancer
LeBeau, A., De For, T. E., Gupta, S., McKenna, D. H., Moriarity, B. S. & Webber, B. R.
12/31/18 → 12/31/20
Project: Research project
Cell- and Tissue-Based Therapy
Natural Killer Cells
Prostatic Neoplasms
Research Output 2005 2019
Correction: Exploiting the transcriptional specificity of the alphamethylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer (Oncotarget (2018) 9 (36693-36704) DOI: 10.18632/oncotarget.26401)
Shapovalova, M., Davydova, J., Henzler, C., Daniel, M., Dehm, S. M., Warlick, C. A. & LeBeau, A., Aug 1 2019, In : Oncotarget. 10, 47, 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Racemases and Epimerases
Molecular Imaging
Coenzyme A
Prostatic Neoplasms
Research
Development of a cross-reactive monoclonal antibody for detecting the tumor stroma
Hintz, H. M., Cowan, A. E., Shapovalova, M. & LeBeau, A., May 15 2019, In : Bioconjugate Chemistry. 30, 5, p. 1466-1476 11 p.Research output: Contribution to journal › Article
Monoclonal antibodies
Fibroblasts
Tumors
Immunoglobulin G
Monoclonal Antibodies
2
Citations
(Scopus)
The identification of a novel antibody for CD133 using human antibody phage display
Glumac, P. M., Forster, C. L., Zhou, H., Murugan, P., Gupta, S. & LeBeau, A., Sep 15 2018, In : Prostate. 78, 13, p. 981-991 11 p.Research output: Contribution to journal › Article
Bacteriophages
Antibodies
Immunohistochemistry
Prostate
Single-Chain Antibodies
1
Citation
(Scopus)
The Molecular Imaging of Natural Killer Cells
Shapovalova, M., Pyper, S. R., Moriarity, B. S. & LeBeau, A., Sep 8 2018, In : Molecular imaging. 17Research output: Contribution to journal › Review article
Molecular Imaging
Natural Killer Cells
Cell- and Tissue-Based Therapy
Immunotherapy
Antibody-Dependent Cell Cytotoxicity
14
Citations
(Scopus)
Engineering of Anti-CD133 trispecific molecule capable of inducing NK expansion and driving antibody-dependent cell-mediated cytotoxicity
Schmohl, J. U., Felices, M., Oh, F., Lenvik, A. J., LeBeau, A., Panyam, J., Miller, J. S. & Vallera, D. A., Jan 1 2017, In : Cancer Research and Treatment. 49, 4, p. 1140-1152 13 p.Research output: Contribution to journal › Article
Antibody-Dependent Cell Cytotoxicity
Natural Killer Cells
Interleukin-15
Neoplastic Stem Cells
Interferons